Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma [Phase 1]
Phase 1 trial of BPI-371153 in advanced solid tumors and lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Cadonilimab is being studied in a Phase 2 trial for advanced non-small cell lung cancer and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation [Phase 1]
This Phase 1 trial is evaluating the safety and preliminary efficacy of IBI351 in combination with chemotherapy for advanced non-squamous no…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: A Study of AL8326 in Non-Small Cell Lung Cancer [Phase 1]
Clinical trial update for AL8326 in non-small cell lung cancer (Phase 1) shows the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing the safety and preliminary efficacy of HB0025 injection in patients with advanced solid tumors, includi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is cur…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients [Phase 1, Phase 2]
The document announces an ongoing Phase 1/2 trial evaluating the combination of nintedanib with an EGFR tyrosine kinase inhibitor in patient…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
This document provides an update on the AI-HOPE Lung Cancer trial, which aims to build a predictive tool for metastatic non-small cell lung …
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
This clinical trial evaluates F-18 FDG PET/CT plus CT for initial staging of non-small cell lung cancer, and the study status is not yet rec…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure
A real-world study is planned to evaluate sunvozertinib in patients with advanced EGFR-mutant non-small cell lung cancer after failure of pr…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients [NA]
This clinical trial investigates whether adding early palliative care by a palliative care specialist to standard care improves outcomes in …
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study [Phase 4]
Phase 4 multicenter real-world study evaluating the efficacy and safety of ensartinib as neoadjuvant therapy for stage IIA-IIIB ALK-positive…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
This clinical trial update describes an artificial intelligence-based model to predict occult lymph node metastasis in non-small cell lung c…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Neoadjuvant Nivolumab with CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 neoadjuvant trial evaluating nivolumab with a CCR2/5 inhibitor or anti-IL-8 in non-small cell lung cancer and hepatocellular carcino…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD [Phase 2]
Phase 2 clinical trial update evaluating adjuvant treatment of ALK-positive non-small cell lung cancer with ensartinib guided by MRD (minima…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Neoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 neoadjuvant trial of ensartinib for ALK-positive resectable stage II to III non-small cell lung cancer is currently not yet recrui…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
Update on the LcProt proteomics longitudinal cohort study investigating lung cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC [Phase 2]
A Phase 2 clinical trial is evaluating Adebrelimab in combination with chemotherapy, with or without Bevacizumab, as neoadjuvant therapy for…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and early signals of efficacy of IAP0971 in patients with advanced malignant tumors, includ…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Comprehensive Demographics and Clinical Profile of NSCLC Patients
This clinical trial update provides the demographics and clinical profile of patients with non-small cell lung cancer in NCT06725537; the st…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
A ClinicalTrials.gov study sponsored by MSD Italia aims to describe how patients with early-stage and locally advanced non-small cell lung c…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk Factors [Phase 2]
A Phase 2 clinical trial evaluating ensartinib as adjuvant therapy for stage I ALK-positive non-small cell lung cancer with high-risk factor…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers [Phase 2]
This Phase 2 trial aims to evaluate whether reducing the dosing frequency of immune checkpoint inhibitors is feasible across advanced cancer…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC [Phase 2]
This document reports a Phase II clinical trial evaluating AK112, a PD-1/VEGF bispecific, in combination with chemotherapy for non-small cel…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models [NA]
Clinical trial update examining the accuracy of targeted lymph node dissection in non-small cell lung cancer using predictive models; the st…